Emerson Beats Q3 Estimates on 23% Test & Measurement Surge, But Shares Dip 2.4% After Hours
EMR sits 25% above its 52-week low of $122.635 on elevated volume (1.8× avg).
Summary
Emerson Electric posted Q3 adjusted EPS of $1.71, beating the $1.68 consensus, on revenue of $4.87B (up 7% YoY) vs. $4.8B expected. The beat was driven by a 23% jump in test and measurement sales and 11% growth in software and systems, reflecting robust North American and Asian automation demand. Europe remained a soft spot with a 1% sales decline, consistent with earlier flagged headwinds in automotive and chemicals. Despite the beat, shares fell 2.4% after hours, suggesting the market may have priced in stronger results or is reacting to the European weakness. This follows the 8-K and 10-Q filed earlier today confirming the same top-line figures; the news adds segment-level color and the initial market reaction.
At the time of this announcement, EMR was trading at $153.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $89B. The 52-week trading range was $122.64 to $165.15. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.